ProQR Therapeutics N.V. Ordinary Shares
Symbol: PRQR (NASDAQ)
2.19
▼ (-0.23%) -0.005
Company Description:
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
Key Stats
- Today's Open: $2.16
- Today's High: $2.25
- Today's Low: $2.045
- Today's Volume: 472.35K
- Yesterday Close: $2.19
- Yesterday High: $2.25
- Yesterday Low: $2.1
- Yesterday Volume: 403.69K
- Last Min Volume: 1
- Last Min High: $2.185
- Last Min Low: $2.185
- Last Min VWAP: $2.185
Company Profile
- Name: ProQR Therapeutics N.V. Ordinary Shares
- Website: https://www.proqr.com
- Listed Date: 2014-09-18
- Location: ,
- Market Status: Active
- CIK Number: 0001612940
- SIC Code:
- SIC description:
- Market Cap: $230.70M
- Round Lot: 100
- Outstanding Shares: 105.34M
- Asset Type: CS
RECENT FILINGS FOR PRQR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-04 | SCHEDULE 13D/A | View |
| 2025-08-20 | SCHEDULE 13D/A | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-07 | 6-K | View |
| 2025-06-26 | 6-K | View |
| 2025-06-03 | 6-K | View |
| 2025-05-28 | SCHEDULE 13D | View |
| 2025-05-12 | SCHEDULE 13G/A | View |
| 2025-05-08 | 6-K | View |
| 2025-05-01 | 6-K | View |
| 2025-04-14 | 6-K | View |
| 2025-03-25 | EFFECT | View |
| 2025-03-25 | 424B5 | View |
| 2025-03-21 | CORRESP | View |
| 2025-03-20 | UPLOAD | View |
| 2025-03-13 | S-8 | View |
| 2025-03-13 | F-3 | View |
| 2025-03-13 | 20-F | View |
| 2025-03-13 | 6-K | View |
| 2025-02-14 | SCHEDULE 13G/A | View |
Latest News on PRQR